Literature DB >> 11799171

Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Jangsuk Oh1, John G Julias, Andrea L Ferris, Stephen H Hughes.   

Abstract

We constructed two versions of an RCASBP-based retroviral shuttle vector, RSVP (RCASBP shuttle vector plasmid), containing either the zeocin or blasticidin resistance gene. In this vector, the drug resistance gene is expressed in avian cells from the long terminal repeat (LTR) promoter, whereas in bacteria the resistance gene is expressed from a bacterial promoter. The vector contains a bacterial origin of replication (ColE1) to allow circular viral DNA to replicate as a plasmid in bacteria. The vector also contains the lac operator sequence, which binds to the lac repressor protein, providing a simple and rapid way to purify the vector DNA. The RSVP plasmid contains the following sequence starting with the 5" end: LTR, gag, pol, env, drug resistance gene, lac operator, ColE1, LTR. After this plasmid was transfected into DF-1 cells, we were able to rescue the circularized unintegrated viral DNA from RSVP simply by transforming the Hirt DNA into Escherichia coli. Furthermore, we were able to rescue the integrated provirus. DNA from infected cells was digested with an appropriate restriction enzyme (ClaI) and the vector-containing segments were enriched using lac repressor protein and then self-ligated. These enriched fractions were used to transform E. coli. The transformation was successful and we did recover integration sites, but higher-efficiency rescue was obtained with electroporation. The vector is relatively stable upon passage in avian cells. Southern blot analyses of genomic DNAs derived from successive viral passages under nonselective conditions showed that the cassette (drug resistance gene-lac operator-ColE1) insert was present in the vector up to the third viral passage for both resistance genes, which suggests that the RSVP vectors are stable for approximately three viral passages. Together, these results showed that RSVP vectors are useful tools for cloning unintegrated or integrated viral DNAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799171      PMCID: PMC135915          DOI: 10.1128/jvi.76.4.1762-1768.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.

Authors:  C J Petropoulos; S H Hughes
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance.

Authors:  D Drocourt; T Calmels; J P Reynes; M Baron; G Tiraby
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.

Authors:  M Himly; D N Foster; I Bottoli; J S Iacovoni; P K Vogt
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

4.  Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells.

Authors:  M Izumi; H Miyazawa; T Kamakura; I Yamaguchi; T Endo; F Hanaoka
Journal:  Exp Cell Res       Date:  1991-12       Impact factor: 3.905

5.  Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants.

Authors:  J C Olsen; C Bova-Hill; D P Grandgenett; T P Quinn; J P Manfredi; R Swanstrom
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions.

Authors:  V K Pathak; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

Authors:  J Schaefer-Klein; I Givol; E V Barsov; J M Whitcomb; M VanBrocklin; D N Foster; M J Federspiel; S H Hughes
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

8.  High efficiency transformation of Tolypocladium geodes conidiospores to phleomycin resistance.

Authors:  T Calmels; M Parriche; H Durand; G Tiraby
Journal:  Curr Genet       Date:  1991-09       Impact factor: 3.886

9.  Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells.

Authors:  M Kimura; A Takatsuki; I Yamaguchi
Journal:  Biochim Biophys Acta       Date:  1994-11-22

10.  Phleomycin resistance as a dominant selectable marker in CHO cells.

Authors:  P Mulsant; A Gatignol; M Dalens; G Tiraby
Journal:  Somat Cell Mol Genet       Date:  1988-05
View more
  11 in total

1.  Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase.

Authors:  Minghao Sun; Jonathan R Hart; Petra Hillmann; Marco Gymnopoulos; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap.

Authors:  David J Garfinkel; Karen M Stefanisko; Katherine M Nyswaner; Sharon P Moore; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

3.  Protein expression profiles of C3H 10T1/2 murine fibroblasts and of isogenic cells transformed by the H1047R mutant of phosphoinositide 3-kinase (PI3K).

Authors:  Jonathan Ross Hart; Lujian Liao; Lynn Ueno; John R Yates; Peter K Vogt
Journal:  Cell Cycle       Date:  2011-03-15       Impact factor: 4.534

4.  Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Alternate polypurine tracts affect rous sarcoma virus integration in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Essential role of Stat3 in PI3K-induced oncogenic transformation.

Authors:  Jonathan R Hart; Lujian Liao; John R Yates; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

7.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.

Authors:  Minghao Sun; Petra Hillmann; Bianca T Hofmann; Jonathan R Hart; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

9.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.